Standout Papers

The NAFLD fibrosis score 2002 2026 2010 2018 2.3k
  1. The NAFLD fibrosis score (2007)
    Paul Angulo, Jason M. Hui et al. Hepatology
  2. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis (2018)
    Zobair M. Younossi, Frank Tacke et al. Hepatology
  3. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome (2002)
    Shivakumar Chitturi, Shehan Abeygunasekera et al. Hepatology
  4. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates (2018)
    Zobair M. Younossi, Maria Stepanova et al. Clinical Gastroenterology and Hepatology
  5. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression (2003)
    Jason M. Hui, Archana Sud et al. Gastroenterology
  6. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study (2018)
    Eduardo Vilar‐Gómez, Luis Calzadilla Bertot et al. Gastroenterology
  7. Cytokines: From Clinical Significance to Quantification (2021)
    Chao Liu, Dewei Chu et al. Advanced Science
  8. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD (2020)
    Sakura Yamamura, Mohammed Eslam et al. Liver International
  9. Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation (2019)
    Fei Chen, Saeed Esmaili et al. Hepatology
  10. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement (2021)
    Mohammed Eslam, Naim Alkhouri et al. ˜The œLancet. Gastroenterology & hepatology
  11. Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight (2022)
    Mohammed Eslam, Hashem B. El‐Serag et al. Nature Reviews Gastroenterology & Hepatology
  12. Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications (2024)
    Jacob George, Liang Qiao et al. Cancer Gene Therapy

Immediate Impact

4 by Nobel laureates 3 from Science/Nature 213 standout
Sub-graph 1 of 15

Citing Papers

Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
25 intermediate papers

Works of Jacob George being referenced

Collagen biology and non‐invasive biomarkers of liver fibrosis
2020
ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis
2018
and 9 more

Author Peers

Author Last Decade Papers Cites
Jacob George 11199 6186 3963 264 14.8k
Elizabeth E. Powell 8964 6422 2400 210 13.4k
Alastair D. Burt 11893 8321 3744 232 17.9k
Manal F. Abdelmalek 12684 5599 6079 204 16.1k
Manuel Romero‐Gómez 10745 7741 2924 400 14.3k
Emmanuel Tsochatzis 11637 9154 2441 298 15.1k
Ali Canbay 8826 5017 2236 376 14.3k
Mark L. Van Natta 14287 6182 5335 111 18.7k
Valério Nobili 11262 3611 5871 283 15.5k
Fabio Marra 10247 7949 2168 279 17.6k
Richard K. Sterling 15359 13320 2821 315 20.0k

All Works

Loading papers...

Rankless by CCL
2026